1 Min Read
June 26 (Reuters) - Basilea Pharmaceutica AG:
* STARTS CLINICAL PHASE 2A EXPANSION WITH BAL101553 IN OVARIAN CANCER AND GLIOBLASTOMA Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.